LEK Registers Third Drug in the USA
Ljubljana, 14 January - PHARMACY/LEK/USA
Slovenia's pharmaceutical producer LEK registered Tuesday its drug Bromokriptin for sale on the U.S. market, the toughest and largest market of generic drugs in the world, Ljubljana-based LEK reported.
The rest of this news item is available to subscribers.
The news item consists of 432 characters (without spaces) or 85 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.